PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Estrogen Receptor Beta 1,924 Target Target Egl Nine Homolog 1 4 1 0.01 -0.87 0.25 0.69
ADRBK2 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
CD62L/L-Selectin 8 Target Disease Cancer 1,053,491 2 0.00 -0.87 0.25 0.55
CCL4 5,638 Target Target CCBL1 4 1 0.01 -0.87 0.25 0.66
Ck-beta-11 4 Target Target Exodus-2 27 1 0.10 -0.85 0.25 0.84
Ck-beta-11 4 Target Disease Breast Cancer 173,695 1 0.00 -0.87 0.25 0.59
Ck-beta-11 4 Target Target CD34 24,598 1 0.00 -0.87 0.25 0.63
Ck-beta-11 4 Target Target Exodus-3 8 1 0.18 -0.81 0.25 0.89
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Target Collagen 138,882 1 0.00 -0.87 0.25 0.59
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Disease Inflammation 252,734 1 0.00 -0.87 0.25 0.58
Xaa-Pro Dipeptidase 4 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.87 0.25 0.64
Xaa-Pro Dipeptidase 4 Target Target EGF 27,487 1 0.00 -0.87 0.25 0.62
CCL2 3,560 Target Target CCL1 220 55 0.06 -0.86 0.25 0.76
Antithrombin 13,773 Target Drug Alprostadil Injection (Caverject)- FDA 4 1 0.00 -0.87 0.25 0.64
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
Glutathione S-Transferase Mu 2 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Prostaglandin Reductase 1 8 Target Disease Inflammation 252,734 2 0.00 -0.87 0.25 0.58
Epidermal Growth Factor Receptor 24,772 Target Target ERBB3 1,154 289 0.05 -0.86 0.25 0.72
CXCL9 1,016 Target Disease Inflammation 252,734 256 0.02 -0.86 0.25 0.63
CD4 112,219 Target Target CD137 474 120 0.02 -0.86 0.25 0.64
CCL3 1,427 Target Disease Inflammation 252,734 365 0.02 -0.86 0.26 0.63
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Glioblastoma 17,933 10 0.01 -0.86 0.26 0.66
CD148 74 Target Target DEP-1 88 19 0.24 -0.76 0.26 0.90
Calmodulin 25,240 Target Target DAPK2 27 7 0.01 -0.86 0.26 0.65
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
Exodus-2 27 Target Target CCL21 808 7 0.05 -0.86 0.26 0.76
CD146 729 Target Target CD34 24,598 190 0.04 -0.86 0.26 0.71
BMP-6 386 Target Target BMP-4 1,255 101 0.15 -0.82 0.26 0.83
CCL2 3,560 Target Target CXCL3 145 38 0.05 -0.85 0.26 0.75
DDR2 194 Target Disease Cancer 1,053,491 51 0.00 -0.86 0.26 0.57
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Mu Opioid Receptor 4,576 Target Target Mu-Type Opioid Receptor 19 5 0.02 -0.86 0.26 0.69
Eotaxin-2/CCL24 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
ACRP30 102 Target Disease Diabetes 332,602 27 0.00 -0.86 0.26 0.59
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
APOE 12,771 Target Disease Cholesterol 182,390 3,396 0.07 -0.85 0.27 0.69
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
Lanosterol 14 Alpha-Demethylase 101 Target Disease Cholesterol 182,390 27 0.01 -0.86 0.27 0.61
CA125 Antigen 78 Target Disease Carcinoma 433,099 21 0.00 -0.85 0.27 0.59
Dihydropteroate Synthase 408 Target Disease Malaria 56,215 110 0.02 -0.85 0.27 0.67
CD22 1,591 Target Disease Leukemia 162,805 430 0.03 -0.85 0.27 0.65
ADSF 11 Target Target Adiponectin 11,994 3 0.01 -0.85 0.27 0.66
Epidermal Growth Factor Receptor 24,772 Target Target Epiregulin 291 80 0.03 -0.85 0.27 0.69
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
Angiotensin Converting Enzyme 31,674 Target Target Aldosterone Receptor 528 146 0.04 -0.85 0.28 0.69
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
Phosphodiesterase 4b 54 Target Disease Schizophrenia 77,034 15 0.01 -0.85 0.28 0.63
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81